Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trellus HealthFRA:85Q OCF Margin % is -858.20% as of Jun. 2025. The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Trellus Health ranks worse than 98.5% on this metric.
The historical rank and industry rank for Trellus Health's OCF Margin % or its related term are showing as below:
FRA:85Q'
s OCF Margin % Range Over the Past 10 Years
Min: -47180 Med: -23331.4 Max: -6434.44
Current: -1784.86
During the past 5 years, the highest OCF Margin % of Trellus Health was -6434.44%. The lowest was -47180.00%. And the median was -23331.40%.
FRA:85Q's OCF Margin % is ranked worse than 98.5% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 8.395
vs FRA:85Q: -1784.86
The historical data trend for Trellus Health's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:85Q vs VEEV, BTSG, TEM: OCF Margin % Comparison
For the Health Information Services subindustry, Trellus Health's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trellus Health OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Trellus Health's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trellus Health (FRA:85Q) has a OCF Margin % of -858.20% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Trellus Health and its competitors. According to the industry distribution chart, Trellus Health ranks #658 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 98.5%.
Is Trellus Health's OCF Margin % too high?
Trellus Health's current OCF Margin % is -858.20%. Based on the distribution chart, Trellus Health ranks #658 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Trellus Health's OCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Trellus Health ranks #658 out of 668 companies for OCF Margin %. This places Trellus Health in the lower half of its industry. The industry median OCF Margin % is 8.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.40, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Trellus Health and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trellus Health's current OCF Margin % is -858.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (FRA:85Q) has a current OCF Margin % of -858.20%. The current OCF Margin % is -858.20%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Trellus Health (FRA:85Q), the current OCF Margin % is -858.20% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:85Q has been successfully added to your 
